TY - JOUR
T1 - Corrigendum to “2019 ESC/EAS Guidelines for the management of dyslipidaemias
T2 - lipid modification to reduce cardiovascular risk” (Atherosclerosis (2019) 290 (140–205), (S0021915019314595), (10.1016/j.atherosclerosis.2019.08.014))
AU - Task Force Members
AU - ESC National Cardiac Societies
AU - ESC Committee for Practice Guidelines (CPG)
AU - Mach, Francois
AU - Baigent, Colin
AU - Catapano, Alberico L.
AU - Koskinas, Konstantinos C.
AU - Casula, Manuela
AU - Badimon, Lina
AU - Chapman, M. John
AU - De Backer, Guy G.
AU - Delgado, Victoria
AU - Ference, Brian A.
AU - Graham, Ian M.
AU - Halliday, Alison
AU - Landmesser, Ulf
AU - Mihaylova, Borislava
AU - Pedersen, Terje R.
AU - Riccardi, Gabriele
AU - Richter, Dimitrios J.
AU - Sabatine, Marc S.
AU - Taskinen, Marja Riitta
AU - Tokgozoglu, Lale
AU - Wiklund, Olov
AU - Nibouche, Djamaleddine
AU - Zelveian, Parounak H.
AU - Siostrzonek, Peter
AU - Najafov, Ruslan
AU - van de Borne, Philippe
AU - Pojskic, Belma
AU - Postadzhiyan, Arman
AU - Kypris, Lambros
AU - Špinar, Jindřich
AU - Larsen, Mogens Lytken
AU - Eldin, Hesham Salah
AU - Viigimaa, Margus
AU - Strandberg, Timo E.
AU - Ferrieres, Jean
AU - Agladze, Rusudan
AU - Laufs, Ulrich
AU - Rallidis, Loukianos
AU - Bajnok, Laszlo
AU - Gudjonsson, Thorbjorn
AU - Maher, Vincent
AU - Henkin, Yaakov
AU - Gulizia, Michele Massimo
AU - Mussagaliyeva, Aisulu
AU - Bajraktari, Gani
AU - Kerimkulova, Alina
AU - Latkovskis, Gustavs
AU - Hamoui, Omar
AU - Slapikas, Rimvydas
AU - Visser, Laurent
N1 - Publisher Copyright:
© 2019 [The Author/The Authors]
PY - 2020/2
Y1 - 2020/2
N2 - In row 4 of Table 3, ‘should’ should read as ‘may’; In 4.2.1, paragraph 3, ‘should’ should read ‘may’ to read ‘Overall, CAC score assessment with CT may be considered in individuals … ’ Also in the second row of ‘Recommendations for cardiovascular imaging for risk assessment of atherosclerotic cardiovascular disease,’ the Class should read ‘llb’; In the second paragraph of 7.5.2, ‘5–10 mg of monacolin K’ should read ‘2.5–10 mg’; and in the Key messages section, number 4, ‘ApoB may be a better measure of an individual's exposure to atherosclerotic lipoproteins' should read ‘ApoB may be a better measure of an individual's exposure to pro atherogenic lipoproteins'.
AB - In row 4 of Table 3, ‘should’ should read as ‘may’; In 4.2.1, paragraph 3, ‘should’ should read ‘may’ to read ‘Overall, CAC score assessment with CT may be considered in individuals … ’ Also in the second row of ‘Recommendations for cardiovascular imaging for risk assessment of atherosclerotic cardiovascular disease,’ the Class should read ‘llb’; In the second paragraph of 7.5.2, ‘5–10 mg of monacolin K’ should read ‘2.5–10 mg’; and in the Key messages section, number 4, ‘ApoB may be a better measure of an individual's exposure to atherosclerotic lipoproteins' should read ‘ApoB may be a better measure of an individual's exposure to pro atherogenic lipoproteins'.
UR - https://www.scopus.com/pages/publications/85076858833
U2 - 10.1016/j.atherosclerosis.2019.12.004
DO - 10.1016/j.atherosclerosis.2019.12.004
M3 - Comment/debate
C2 - 31870624
AN - SCOPUS:85076858833
SN - 0021-9150
VL - 294
SP - 80
EP - 82
JO - Atherosclerosis
JF - Atherosclerosis
ER -
SKH 3 Sağlık ve Kaliteli Yaşam